{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:58:49Z","timestamp":1759010329610},"reference-count":10,"publisher":"Centers for Disease Control MMWR Office","issue":"24","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["MMWR Morb. Mortal. Wkly. Rep."],"DOI":"10.15585\/mmwr.mm6624a5","type":"journal-article","created":{"date-parts":[[2017,6,22]],"date-time":"2017-06-22T10:21:04Z","timestamp":1498126864000},"page":"649-652","source":"Crossref","is-referenced-by-count":14,"title":["Progress Toward Containment of Poliovirus Type 2 \u2014 Worldwide, 2017"],"prefix":"10.15585","volume":"66","author":[{"given":"Nicoletta","family":"Previsani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harpal","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeanette","family":"St. Pierre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liliane","family":"Boualam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacqueline","family":"Fournier-Caruana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roland W.","family":"Sutter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel","family":"Zaffran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"MEng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"6224","published-online":{"date-parts":[[2017,6,23]]},"reference":[{"key":"key-10.15585\/mmwr.mm6624a5-201706221020-R1","doi-asserted-by":"publisher","first-page":"538","DOI":"10.15585\/mmwr.mm6620a4","article-title":"Virologic monitoring of poliovirus type 2 after oral poliovirus vaccine type 2 withdrawal in April 2016\u2014worldwide, 2016\u20132017.","volume":"66","author":"Diop","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.mm6624a5-201706221020-R2","doi-asserted-by":"publisher","first-page":"913","DOI":"10.15585\/mmwr.mm6433a5","article-title":"World Health Organization guidelines for containment of poliovirus following type-specific polio eradication\u2014worldwide, 2015.","volume":"64","author":"Previsani","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.mm6624a5-201706221020-R3","unstructured":"Global Polio Eradication Initiative. Polio eradication and endgame strategic plan 2013\u20132018. Geneva, Switzerland: World Health Organization; 2013. http:\/\/polioeradication.org\/who-we-are\/strategy\/"},{"key":"key-10.15585\/mmwr.mm6624a5-201706221020-R4","doi-asserted-by":"publisher","first-page":"470","DOI":"10.15585\/mmwr.mm6518a4","article-title":"Progress toward polio eradication\u2014worldwide, 2015\u20132016.","volume":"65","author":"Morales","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.mm6624a5-201706221020-R5","doi-asserted-by":"publisher","first-page":"190","DOI":"10.15585\/mmwr.mm6607a2","article-title":"Continued endemic wild poliovirus transmission in security-compromised areas\u2014Nigeria, 2016.","volume":"66","author":"Nnadi","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.mm6624a5-201706221020-R6","first-page":"561","article-title":"Meeting of the Strategic Advisory Group of Experts on immunization, October 2016\u2014conclusions and recommendations.","volume":"91","author":"World Health Organization","year":"2016","journal-title":"Wkly Epidemiol Rec"},{"key":"key-10.15585\/mmwr.mm6624a5-201706221020-R7","unstructured":"World Health Organization. WHO Global Action Plan to minimize poliovirus facility-associated risk after type-specific eradication of wild polioviruses and sequential cessation of oral polio vaccine use\u2014GAPIII. Geneva, Switzerland: World Health Organization; 2015. http:\/\/www.polioeradication.org\/wp-content\/uploads\/2016\/12\/GAPIII_2014.pdf"},{"key":"key-10.15585\/mmwr.mm6624a5-201706221020-R8","unstructured":"World Health Organization. Containment certification scheme to support the WHO Global Action Plan for Poliovirus Containment (GAPIII-CCS). Geneva, Switzerland: World Health Organization; 2017."},{"key":"key-10.15585\/mmwr.mm6624a5-201706221020-R9","unstructured":"Global Commission for the Certification of Poliomyelitis Eradication. Summary of findings, decisions and recommendations. Presented at the 14th Meeting of the Global Commission for the Certification of Poliomyelitis Eradication, Bali, Indonesia; September 20\u201321, 2015."},{"key":"key-10.15585\/mmwr.mm6624a5-201706221020-R10","unstructured":"European Center for Disease Control. Poliomyelitis-facility-related infection with WPV2\u2014Netherlands. Communicable disease threats report. Week 16, April 16\u201322, 2017. Solna, Sweden: European Center for Disease Control; 2017. http:\/\/ecdc.europa.eu\/en\/publications\/Publications\/Communicable-disease-threats-report-22-apr-2017.pdf"}],"container-title":["MMWR. Morbidity and Mortality Weekly Report"],"original-title":[],"deposited":{"date-parts":[[2017,6,22]],"date-time":"2017-06-22T10:21:04Z","timestamp":1498126864000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.cdc.gov\/mmwr\/volumes\/66\/wr\/mm6624a5.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,23]]},"references-count":10,"journal-issue":{"issue":"24","published-online":{"date-parts":[[2017,6,23]]}},"URL":"https:\/\/doi.org\/10.15585\/mmwr.mm6624a5","relation":{},"ISSN":["0149-2195","1545-861X"],"issn-type":[{"type":"print","value":"0149-2195"},{"type":"electronic","value":"1545-861X"}],"subject":[],"published-other":{"date-parts":[[2017,6,23]]},"published":{"date-parts":[[2017,6,23]]}}}